Minocycline Hydrochloride

盐酸米诺环素

Report date: 2026/05/15 20:01:45
NMEQIDP

Base Information

Drug NameMinocycline Hydrochloride
Drug Alias NameMinociclina盐酸米洛环素Minocyclinum米诺环素盐酸盐盐酸二甲胺四环素 +[32] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitorsPoly (ADP-Ribose) polymerase 1 inhibitors
Targets30S ribosomal subunitPoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsDiabetic macular oedemaConfluent and Reticulated Papillomatosis (CARP)Neuroinflammatory Diseases +[137] 
Global Approved IndicationsAcne VulgarisPeriodontitisLeprosy +[5] 
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryN/A
Original Approved Date1961/01/01
Country/TerritoryCanadaUnited StatesSweden +[20] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesJourney Medical CorpCase Western Reserve UniversityBeijing Tiantan Hospital, Capital Medical University +[20] 
Inactive CompaniesAugusta UniversityBausch Health Us LlcLeonard-Meron Biosciences Inc +[42] 
Active IndicationsConfluent and Reticulated Papillomatosis (CARP)Neuroinflammatory DiseasesIschemic Stroke +[59] 
Inactive IndicationsDiabetic macular oedemaBipolar II DisorderBipolar I Disorder +[78] 

Other Information

ATC CodeA01AB23J01AA08
Related LinksWikipediaDrugBankKEGG